These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 36560948)

  • 1. Recent advances to combat ESKAPE pathogens with special reference to essential oils.
    Panda SK; Buroni S; Swain SS; Bonacorsi A; da Fonseca Amorim EA; Kulshrestha M; da Silva LCN; Tiwari V
    Front Microbiol; 2022; 13():1029098. PubMed ID: 36560948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
    Pandey R; Mishra SK; Shrestha A
    Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytocompound Mediated Blockage of Quorum Sensing Cascade in ESKAPE Pathogens.
    Ghosh S; Lahiri D; Nag M; Dey A; Pandit S; Sarkar T; Pati S; Abdul Kari Z; Ishak AR; Edinur HA; Ray RR
    Antibiotics (Basel); 2022 Jan; 11(1):. PubMed ID: 35052938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens.
    Artini M; Papa R; Vrenna G; Trecca M; Paris I; D'Angelo C; Tutino ML; Parrilli E; Selan L
    Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?
    Yu Z; Tang J; Khare T; Kumar V
    Fitoterapia; 2020 Jan; 140():104433. PubMed ID: 31760066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.
    Jadimurthy R; Mayegowda SB; Nayak SC; Mohan CD; Rangappa KS
    Biotechnol Rep (Amst); 2022 Jun; 34():e00728. PubMed ID: 35686013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
    Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
    Front Microbiol; 2019; 10():539. PubMed ID: 30988669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review.
    Sahoo A; Swain SS; Behera A; Sahoo G; Mahapatra PK; Panda SK
    Front Microbiol; 2021; 12():661195. PubMed ID: 34248873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foodborne ESKAPE Biofilms and Antimicrobial Resistance: lessons Learned from Clinical Isolates.
    Patil A; Banerji R; Kanojiya P; Saroj SD
    Pathog Glob Health; 2021 Sep; 115(6):339-356. PubMed ID: 33851566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
    Tiwari V; Meena K; Tiwari M
    Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting ESKAPE Pathogens: virulence, resistance, and combating strategies focusing on quorum sensing.
    Venkateswaran P; Vasudevan S; David H; Shaktivel A; Shanmugam K; Neelakantan P; Solomon AP
    Front Cell Infect Microbiol; 2023; 13():1159798. PubMed ID: 37457962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesol Emulsion as an Effective Broad-Spectrum Agent against ESKAPE Biofilms.
    Tan L; Ma R; Katz AJ; Levi N
    Antibiotics (Basel); 2024 Aug; 13(8):. PubMed ID: 39200078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quorum Sensing in ESKAPE Bugs: A Target for Combating Antimicrobial Resistance and Bacterial Virulence.
    Santajit S; Sookrung N; Indrawattana N
    Biology (Basel); 2022 Oct; 11(10):. PubMed ID: 36290370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.
    Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF
    Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.
    Du H; Puri S; McCall A; Norris HL; Russo T; Edgerton M
    Front Cell Infect Microbiol; 2017; 7():41. PubMed ID: 28261570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.
    Saha U; Gondi R; Patil A; Saroj SD
    Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.
    Ma YX; Wang CY; Li YY; Li J; Wan QQ; Chen JH; Tay FR; Niu LN
    Adv Sci (Weinh); 2020 Jan; 7(1):1901872. PubMed ID: 31921562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-thermal Plasma Treatment of ESKAPE Pathogens: A Review.
    Scholtz V; Vaňková E; Kašparová P; Premanath R; Karunasagar I; Julák J
    Front Microbiol; 2021; 12():737635. PubMed ID: 34712211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.